Medical Device
Manufacturing
THE TRADE PAPER OF THE FACTORY FLOOR
Z-1896-2026Class II

Avitene Ultrafoam Microfibrillar Collagen Hemostat - 8cm x 6.25cm x 1cm. Catalog Number: 1050030

Davol Inc., Sub. C.R. Bard, Inc. / initiated 2026-03-25 / Open, Classified

Davol, Inc. began a recall of Avitene Ultrafoam Microfibrillar Collagen Hemostat - 8cm x 6.25cm x 1cm. Catalog Number: 1050030 on . FDA classified it as Class II and gives the reason as "Potential for product to contain foreign matter, confirmed to be inspect fragments". As of , the recall status on record is Open, Classified.

Recall record

Recall number
Z-1896-2026
Classification
Class II
Status
Open, Classified
Initiated
Posted
Recalling firm
Davol Inc., Sub. C.R. Bard, Inc.
Product
Avitene Ultrafoam Microfibrillar Collagen Hemostat - 8cm x 6.25cm x 1cm. Catalog Number: 1050030.
Product code
LMF Agent, Absorbable Hemostatic, Collagen Based
Reason for recall
Potential for product to contain foreign matter, confirmed to be inspect fragments.
FDA root cause
Under Investigation by firm
Action
Davol, Inc. (Subsidiary of C.R. Bard, Inc.) notified consignees on about 03/25/2026 via emailed and mailed letter. Consignees were instructed to immediately discontinue use of and destroy any affected products on hand, hold in quarantine if destruction is not immediately possible, and complete and return the provided Customer Response Form. Consignees were also instructed to share the notification with anyone who needs to be aware within your organization and forwarded to any organization where affected products have been transferred. If affected product was purchased from a distributor, contact that distributor directly for further instructions and credit resolution. Distributors were instructed to immediately discontinue use of and destroy any affected products on hand, hold in quarantine if destruction is not immediately possible, and complete and return the provided Distributor Response Form. Distributors were further instructed to identify all customers within their distribution network who may have purchased any of the affected product listed in the notification and to provide a copy of the provided customer letter to all customers who may have received the affected product to advise them of this recall notification on BD s behalf. BD will issue replacement for destroyed product of the specific lot number identified above to customers that purchased the affected product directly from BD, following receipt of the completed Customer Response Form. BD will implement appropriate corrective and preventive actions, as warranted, to reduce the risk of recurrence.
Quantity in commerce
1,622 units
Distribution
Worldwide distribution - US Nationwide and the countries of China, South Korea.
Product codes and lots
Catalog Number: 1050030. UDI: (01)00801741010538(17)270728(10)WBJS0055. Lot Number: WBJS0055. Expiration Date: 07/28/2027

Enforcement reports

One row per recalled product line
FDA enforcement reports joined to recall event Z-1896-2026
Recall numberClassStatusVoluntary or mandatedReport dateClassified
Z-1896-2026Class IIOngoingVoluntary: Firm initiated